The Rs 429-crore personal care arm of Ahmedabad-based pharmaceutical giant Cadila Healthcare, Zydus Wellness Ltd, which has been clocking a 3-4 per cent compounded growth rate in revenues for the past few years, has drawn up plans to propel the ... Smart Investor, 1 day ago
Cadila to acquire two drug forms from Teva to strengthen its US portfolio - Domain-B, 1 week ago
Cadila Healthcare ends in green; buys two ANDAs from Teva - India Infoline, 1 week ago
|Indian Express, 3 days ago Pankaj Patel selected as head of new se... Pankaj Patel selected as head of new search panel AhmedabadMirror.com, 1 hour ago|
SENSEX 26544.79 149.08 0.56% NIFTY 8145.75 36.90 0.46% Industry: Medical/Healthcare Company Cadila Healthcare Ltd Cadila Healthcare is currently trading at Rs. 321.00, up by 1.90 points or 0.60% from its previous closing of ...Finalaya.com, 1 week ago Cadila Healthcare gains after tie-up with Turkish firm Business Standard, 1 week ago Zydus Cadila enters into strategic collaboration with Turkish healthcare company Moneycontrol.com, 1 week ago Cadila up 2% on USFDA nod for clinical trials of diabetes drug Moneycontrol.com, 3 weeks ago
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - Cadila Healthcare, SREI Infrastructure, Gammon India Max Financial Services.Money Control, 1 week ago
Healthcare provider Zydus Cadila, on Wednesday, announced the signing of a collaboration agreement with Turkey's Eczacibasi Ilac Pazarlama, A.S., to market biotech products in the Turkish market. The agreement involves import of biosimilars which ...Hindu Business Line, 1 week ago Zydus Cadila and Eczacibasi enter into a strategic collaboration to market biosimilars in Turkey Equity Bulls, 1 week ago
NEW DELHI: Drug firm Zydus Cadila and Turkey based healthcare firm, Eczacibasi Ilac Pazarlama have signed a pact to market biotech products in the Turkish market. The collaboration agreement involves the import of bio-similars that are currently ...Economic Times, 1 week ago Zydus Cadila, Eczacibasi ink pact to market biotech products NetIndia123.com, 1 week ago Zydus Group, Eczacibasi Ink Pact To Market Biotech Products NDTV, 1 week ago
More from: , Daily Excelsior.com...and 2 other sources
Indian Pharmaceutical Market - Leading Domestic Companies (Cipla, Cadila Healthcare, IPCA Laboratories)
(Before It's News) This report discusses the Indian pharmaceutical industry in depth, with specific focus on the ten leading domestic India pharmaceutical companies; their key financials since FY2011; their key global markets; their Merger, ...Before It's News, 1 week ago Indian pharma segment may not be impacted by Brexit PharmaBiz, 1 day ago GMR Data - The Indian Pharmaceutical Market - Leading Domestic Companies 2015 International Business Times, 1 week ago Doing business in the US pharma market has become more expensive & challenging for Indian companies Economic Times, 3 weeks ago
Folate, also known as vitamin B9, is most noted for its role in supporting a healthy pregnancy and fetal development. It is a synthetic folate compound used in vitamin supplements and fortified food because of its increased stability. It is also ...MyNewsDesk, 10 hours ago Folate Market Growth with Worldwide Industry Analysis to 2026 MyNewsDesk, 1 month ago
Male infertility market is expected to grow to $301.5 million by 2020 with a CAGR of 5% during 2014-2020.
The male infertility market is expected to grow to $301.5 million by 2020 with a CAGR of 5% during 2014-2020. Male infertility is defined as the inability of a male to impregnate his female partner after a year of unprotected intercourse. 20% of the ...MyNewsDesk, 15 hours ago At a CAGR of 10.53%, Global Generic Drugs Market 2016-2020, Market Analysis and Statistics Report MyNewsDesk, 5 days ago Generic Drugs Market Segmentation, Parameters and Prospects 2016 to 2020 Market Research Report Before It's News, 1 week ago Global Generic Drugs Market 2016-2020 - New Study Released [ClickPress (UK)] Pharmacy Choice, 1 week ago
By Carl O'DonnellJune 27 (Reuters) - Australian pharmaceutical company Mayne Pharma Group Ltd is nearing a deal to purchase assets from Teva Pharmaceuticals worth around $600 million, a person familiar with the matter said on Monday.The deal is the ...Sharenet, 1 day ago UPDATE 1-Mayne Pharma nears deal for Teva assets -source Reuters UK, 1 day ago Crisil rings warning bell for pharma on US slowdown Economic Times, 1 month ago
on your WebpageAdd Widget >Get your members hooked!